EGFR-IN-29 is a potentEGFRinhibitor, example J-022, extracted from Patent WO2021160087^[1].

EGFR-IN-29 inhibits Ba/F3 cells with stable overexpression of △19del/T790M/C797S mutant genes, cells overexpressing EGFR WT and A431 carrying EGFR WT with IC₅₀values of 6.8 nM, 151 nM and 1128 nM, respectively.

733.68

C₃₆H₄₆BrN₈O₂P

2682200-93-5

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.